The Institute of Medicine unveiled its report on food and drug import safety Wednesday and called on the G-20 to endorse its findings and recommendations. The report addresses regulatory gaps and vulnerabilities abroad.
Titled the, “Ensuring Safe Foods and Medical Products Through Stronger Regulatory Systems Abroad,” the report’s authors issued 13 recommendations. The report also focused on how the U.S. can ensure that food and drug imports are as safe as domestic products.
One involves sharing inspection reports between the U.S. and other technologically advanced nations in order to eliminate overlapping inspections.
Another involves greater incentives for countries that do have tough oversight and strong safety records.